VIMTALABSNSEVimta Labs Limited· PharmaceuticalsHighPositive
Announced Mon, 28 Apr · 18:49 IST

Vimta Labs Limited has informed the Exchange that Board of Directors at its meeting held on April 28, 2025, recommended Final Dividend of 2 per equity share.

Corporate Actions View source PDF

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board of Directors of Vimta Labs Limited, at its meeting held on April 28, 2025, has recommended a Final Dividend of ₹2 per equity share for its shareholders. The dividend is subject to approval by the shareholders at the upcoming Annual General Meeting. The record date and book closure dates would be announced separately. This is part of the company's regular dividend declaration following its financial year-end results.

Likely market impact

The ₹2 per share final dividend rewards shareholders with a modest payout, though the exact yield depends on the current share price. This signals continued shareholder returns and financial stability, but is unlikely to drive a significant short-term price reaction.